Single-blind
One side — usually the participant — does not know which treatment is which.
What it means
In a single-blind study, one group of people involved is kept unaware of the treatment assignment. Most often that is the participant, while the study team knows.
Why it matters if you take part
It reduces the chance that knowing your assignment changes how you report your symptoms, while still letting the team manage your care with full information.
Related terms
Trials recruiting now that are single-blind
366 recruiting trials in our Canadian corpus are single-blind.
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell · PHASE3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer · PHASE3
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma (PDAC) · PHASE2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF) · PHASE2
LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY
Mitral Regurgitation · NA
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma · PHASE3
This explains how clinical research works. It is not medical advice and does not describe any specific condition or treatment. Only a trial site can determine whether someone can take part in a study.